Nikolich-Žugich Janko, Goldman Dana P, Cohen Paul R, Cortese Denis, Fontana Luigi, Kennedy Brian K, Mohler M Jane, Olshansky S Jay, Perls Thomas, Perry Daniel, Richardson Arlan, Ritchie Christine, Wertheimer Anne M, Faragher Richard G A, Fain Mindy J
Arizona Center on Aging, Department of Immunobiology, and Department of Medicine, University of Arizona College of Medicine, Tucson. Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles. School of Information, University of Arizona College of Science, Tucson.
Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles.
J Gerontol A Biol Sci Med Sci. 2016 Apr;71(4):435-44. doi: 10.1093/gerona/glv164. Epub 2015 Sep 29.
Although the demographic revolution has produced hundreds of millions people aged 65 and older, a substantial segment of that population is not enjoying the benefits of extended healthspan. Many live with multiple chronic conditions and disabilities that erode the quality of life. The consequences are also costly for society. In the United States, the most costly 5% of Medicare beneficiaries account for approximately 50% of Medicare's expenditures. This perspective summarizes a recent workshop on biomedical approaches to best extend healthspan as way to reduce age-related dysfunction and disability. We further specify the action items necessary to unite health professionals, scientists, and the society to partner around the exciting and palpable opportunities to extend healthspan.
尽管人口结构变革造就了数亿65岁及以上的老年人，但这一群体中的很大一部分并未享受到健康寿命延长带来的益处。许多人患有多种慢性疾病和残疾，生活质量因此受到影响。这对社会而言成本也很高。在美国，医保支出最高的5%的医保受益人约占医保总支出的50%。本观点总结了近期一场关于生物医学方法的研讨会，该方法旨在最大程度地延长健康寿命，以此减少与年龄相关的机能障碍和残疾。我们进一步明确了必要的行动事项，以便团结医疗专业人员、科学家和社会各界，围绕延长健康寿命这一令人兴奋且切实可行的机遇展开合作。
